Mitogen-Activated Protein Kinase Kinase 2 (MAP2K2) (C-Term) Peptide
-
- Target See all MEK2 (MAP2K2) products
- MEK2 (MAP2K2) (Mitogen-Activated Protein Kinase Kinase 2 (MAP2K2))
- Peptide Type
- Synthetic
- Protein Region
- C-Term
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Supplier Product No.
- 000-001-gq2
- Supplier
- Rockland
- Purpose
- MEK2 C-Term Blocking Peptide
- Characteristics
- MAP2K2, MEK, MEK2, MKK2, PRKMK2 ,CFC4, MEK-2 Blocking Peptide, MEK-2 Control Peptide
- Purity
- Greater than 95% specific peptide by analysis by HPLC and by reducing and non-reducing SDS-PAGE.
-
-
- Application Notes
-
Application Note: MEK2 C-term blocking peptide is suitable as a control for polyclonal or monoclonal Anti-MEK2 in immunological assays.
Western Blot Dilution: 50 ng
Other: Dot Blot
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
-
Reconstitution Buffer: Restore with deionized water (or equivalent)
Reconstitution Volume: 50μL
- Concentration
- 1.0 mg/mL
- Buffer
-
Buffer: None
Stabilizer: None
Preservative: 0.01 % (w/v) Sodium Azide - Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- 4 °C,-20 °C
- Storage Comment
- Store vial at 2-8 °C prior to opening. Aliquot contents and freeze at -20 °C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. Dilute only prior to immediate use.
- Expiry Date
- 6 months
-
- Target
- MEK2 (MAP2K2) (Mitogen-Activated Protein Kinase Kinase 2 (MAP2K2))
- Background
- Background: Mitogen-activated protein kinase kinase 2, also known as MEK2 or MKK2, is an integral component of the MAP kinase cascade that regulates cell growth and differentiation. This pathway also plays a key role in synaptic plasticity in the brain. Activated MEK 2 acts as a dual specificity kinase phosphorylating both a threonine and a tyrosine residue on MAP kinase. MEK1 and MEK2 are about 80 % identical to each other, and nearly identical within the kinase domain. MEK2 is ideal for investigators involved in Neuroscience, Cell Signaling and Cancer Research.
- UniProt
- P36507
-